Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
Marko Lucijanić, Ivan Krečak, Ena Sorić, Martina Sedinić, Anica Sabljić, Lovorka Đerek, Ozren Jakšić, Rajko Kušec
Abstract
Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
Topics & Concepts
ThrombocytosisMedicineCoronavirus disease 2019 (COVID-19)Polycythemia veraHematology2019-20 coronavirus outbreakInternal medicineMyeloproliferative DisordersSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyGastroenterologyPathologyPlateletDiseaseInfectious disease (medical specialty)OutbreakMyeloproliferative Neoplasms: Diagnosis and TreatmentHemoglobinopathies and Related DisordersMuscle and Compartmental Disorders